Study on Performance Data of Idylla™ NRAS-BRAF Mutation Assay at 71st AACC Annual Scientific Meeting in Anaheim, CA (US)

    NEXT STORY
    AB Science provides an update on its masitinib clinical program
    PREV STORY
    Telix Pharmaceuticals and German Cancer Research Center (DKFZ) Enter into Collaboration and Option Agreement for Image-Guided Prostate Surgery
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Melinta Therapeutics Publishes Complete Results from Phase III TANGO 2 Study of Vabomere™ (meropenem and vaborbactam)

    Vabomere monotherapy was associated with increased clinical cure, decreased mortality, and was well tolerated ...

    author_avatar
    NASDAQ Market News

    Global Precision Medicine Market 2020-2030: Remodeling the One-Size-Fits-All Theory to Individually Tailored Therapy

    author_avatar
    NASDAQ Market News

    Moleculin Announces Outlicensing Deal To Accelerate Preclinical and Clinical Development

    author_avatar
    NASDAQ Market News